Stay updated on Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Page revision updated to v3.3.4; the previous revision v3.3.3 was replaced.
    Difference
    0.0%
    Check dated 2026-01-14T02:04:56.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added a 'Locations' section with study sites across CA, CO, FL, GA, IN, MD, MN, NY, TX, VT, NSW, QLD, and VIC. This helps users identify enrollment sites.
    Difference
    1.0%
    Check dated 2025-12-23T09:17:42.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page header now shows Revision: v3.3.2, replacing the previous Revision: v3.3.1. This is a metadata update that does not affect study content or user-facing details.
    Difference
    0.0%
    Check dated 2025-12-01T17:27:41.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    - The page shows a system revision from v3.2.0 to v3.3.1 with no user-visible changes to study content or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T14:32:40.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Removed the generic government funding status notice from the page. The study details, locations, and eligibility criteria remain unchanged.
    Difference
    0.2%
    Check dated 2025-11-17T06:40:25.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Results have been posted (Results First Posted 2025-04-24) and the study is reported as terminated early due to not meeting primary and key secondary endpoints, with safety outcomes summarized.
    Difference
    0.3%
    Check dated 2025-11-03T01:16:16.000Z thumbnail image

Stay in the know with updates to Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial page.